SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review

Table 18 Adverse effects of sodium glucose cotransporter-2 inhibitors in individual studies

Study	No. of adverse events	No. of patients	Types of adverse events
Kuchay et al[11]	3	25	Nonspecific fatigue: 1
			Arthralgia: 1
			Balanoposthitis: 1
Ito et al[12]	9	32	UTI: 3
			Increased appetite: 2
			Nausea: 1
			Headache: 1
			Diarrhoea: 1
			Vaginal candidiasis: 1
Eriksson et al[14]	7	21	-
Seko et al[16]	2	26	UTI: 2
Gautam et al[17]	1	32	Recurrent UTI with genital candidiasis: 1
Sumida et al[18]	8	40	Low blood pressure: 3
			Vaginal itching: 2
			Constipation: 1
			Vertigo: 1
			Dehydration: 1
Total	30	176	Most common adverse event: Genitourinary tract infections-10

UTI: Urinary tract infection.